B. Olas et B. Wachowicz, CISPLATIN-INDUCED CHANGES IN BIOLOGICAL-ACTIVITY OF BLOOD-PLATELETS -THIOL-RELATED MECHANISMS, Anti-cancer drugs, 7(4), 1996, pp. 476-482
The effects of cisplatin (cis-diamminedichloroplatinum(II), CDDP) and
transplatin (trans-diamminedichloroplatinum(II), TDDP), and their comp
lexes with glutathione (GS-Pt) in vitro on oxygen free radical generat
ion (O-2(-.)), lipid peroxidation and ADP-induced aggregation in pig b
lood platelets were studied, Incubation of pig blood platelets with ci
splatin or transplatin caused a loss of both protein -SH and the thiol
groups of GSH. In pig blood platelets exposed to cisplatin or transpl
atin (20 mu M) the GS-Pt complex was formed as a major metabolite, The
formation of GS-Pt complexes in platelet cytosol was time dependent a
nd the intracellular content of this complex reached a maximal level a
fter 24 h, GS-Pt complexes were found to induce platelet lipid peroxid
ation, measured as thiobarbituric acid reactive substance level, and 0
(2)(-.) generation, and it was more active than cisplatin or transplat
in alone. Cisplatin and its GS-Pt complex had an inhibitory effect on
ADP-induced platelet aggregation. These results showed that GS-Pt comp
lexes affect platelet metabolism and function. It seems that glutathio
ne-associated metabolism of platinum compounds plays an important role
in the cytotoxicity and biological activity of these drugs.